Related Experiment Video
Updated: May 15, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
Published on: April 8, 2012
Saffold virus type 3 (SAFV-3) persists in HeLa cells
Toshiki Himeda1, Takushi Hosomi, Takako Okuwa
1Department of Microbiology, Kanazawa Medical University School of Medicine, Ishikawa, Japan.
Abstract:
Saffold virus (SAFV) was identified as a human cardiovirus in 2007. Although several epidemiological studies have been reported, they have failed to provide a clear picture of the relationship between SAFV and human diseases. SAFV genotype 3 has been isolated from the cerebrospinal fluid specimen of patient with aseptic meningitis. This finding is of interest since Theiler's murine encephalomyelitis virus (TMEV), which is the closely related virus, is known to cause a multiple sclerosis-like syndrome in mice. TMEV persistently infects in mouse macrophage cells in vivo and in vitro, and the viral persistence is essential in TMEV-induced demyelinating disease. The precise mechanism(s) of SAFV infection still remain unclear. In order to clarify the SAFV pathogenicity, in the present study, we studied the possibilities of the in vitro persistent infection of SAFV. The two distinct phenotypes of HeLa cells, HeLa-N and HeLa-R, were identified. In these cells, the type of SAFV-3 infection was clearly different. HeLa-N cells were lyticly infected with SAFV-3 and the host suitable for the efficient growth. On the other hand, HeLa-R cells were persistently infected with SAFV-3. In addition, the SAFV persistence in HeLa-R cells is independent of type I IFN response of host cells although the TMEV persistence in mouse macrophage cells depends on the response. Furthermore, it was suggested that SAFV persistence may be influenced by the expression of receptor(s) for SAFV infection on the host cells. The present findings on SAFV persistence will provide the important information to encourage the research of SAFV pathogenicity.
Insights
Saffold virus (SAFV) can persistently infect human cells, unlike its related virus TMEV. This persistent infection in HeLa-R cells is independent of the host
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Saffold virus (SAFV), a human cardiovirus, was identified in 2007.
- Epidemiological studies have not clarified the link between SAFV and human diseases.
- SAFV genotype 3 has been found in cerebrospinal fluid of patients with aseptic meningitis, similar to TMEV which causes a multiple sclerosis-like syndrome in mice.
Purpose of the Study:
- To investigate the in vitro persistent infection of Saffold virus (SAFV).
- To clarify the pathogenicity mechanisms of SAFV.
- To compare SAFV infection patterns with Theiler's murine encephalomyelitis virus (TMEV).
Main Methods:
- Utilized two distinct HeLa cell phenotypes (HeLa-N and HeLa-R) to study SAFV-3 infection.
- Assessed viral growth and persistence in different cell types.
- Investigated the role of type I interferon response in SAFV persistence.
Main Results:
- HeLa-N cells supported lytic SAFV-3 infection and efficient viral growth.
- HeLa-R cells exhibited persistent SAFV-3 infection.
- SAFV persistence in HeLa-R cells was independent of the host's type I interferon response, contrasting with TMEV persistence.
Conclusions:
- SAFV can establish persistent infections in human cells (HeLa-R).
- SAFV persistence mechanisms differ from TMEV, notably being independent of type I IFN response.
- Receptor expression on host cells may influence SAFV persistence, warranting further research into SAFV pathogenicity.

